Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
1121P Costs of dacomitinib versus placebo in...
Journal article

1121P Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26

Authors

Karim S; Ding K; Bradbury P; Ellis P; Mittman N; Sun XX; Millward M; Liu G; Sun S; Stockler MR

Journal

Annals of Oncology, Vol. 28, ,

Publisher

Elsevier

Publication Date

9 2017

DOI

10.1093/annonc/mdx375.009

ISSN

0923-7534